Omega Therapeutics
OT
About
Omega Therapeutics is a biotechnology company focused on developing a novel class of therapeutics called Epigenomic Controllers (ECs). These ECs are designed to precisely modulate gene expression by targeting specific epigenetic marks, offering a new approach to treating a wide range of diseases.
Key facts
At-a-glance profile data
- Website
- omegatherapeutics.com
- Headquarters
- Cambridge, United States
- Founded
- 2017
- Total funding
- -
- Business model
- B2B
Tech stack
Detected on omegatherapeutics.com, last scanned 6 Jun 2026. Run your own scan
- Email provider
- Microsoft 365
Add first review
Frequently asked
What is Omega Therapeutics's current status?
Omega Therapeutics's current operating status is: Inactive.